𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1353 A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B

✍ Scribed by Lai, C.L.; Ahn, S.H.; Lee, K.S.; Um, S.H.; Cho, M.; Yoon, S.K.; Lee, J.W.; Park, N.W.; Kwon, Y.O.; Sohn, J.H.; Lee, J.Y.; Park, H.E.; Kim, J.A.; Han, K.H.; Yuen, M.F.

Book ID
122858707
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
146 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of entecavir versus
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study
✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 436 KB πŸ‘ 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score β‰₯7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up